Collegium Pharmaceutical Inc.

Collegium Pharmaceutical reported Q2 adjusted EPS of $1.92, beating consensus, but revenue of $199.9 million missed $201.4 million estimate. Full‑year 2026 revenue guidance lowered to $825‑$855 millio